The global Salbutamol Inhalation market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The salbutamol inhalation market has been growing steadily in recent years due to the rising incidence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and bronchitis. Salbutamol inhalation is a bronchodilator medication that helps to relax the muscles in the airways, making it easier to breathe. It is widely used as a rescue medication for the treatment of acute asthma attacks and as a maintenance medication for the prevention of asthma symptoms.The increasing prevalence of respiratory diseases, coupled with the growing awareness of the benefits of early diagnosis and treatment, is driving the demand for salbutamol inhalation products. In addition, the rise in air pollution levels and the growing prevalence of smoking are also contributing to the growth of the salbutamol inhalation market.The market is also witnessing a trend towards the development of more effective and convenient inhalation devices, such as metered-dose inhalers, dry powder inhalers, and nebulizers. These devices offer greater convenience, ease of use, and improved drug delivery, which is driving their adoption in the market.
Salbutamol Inhalation comes as a spray or aerosol that is used to treat asthma and other respiratory conditions.
This report aims to provide a comprehensive presentation of the global market for Salbutamol Inhalation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Salbutamol Inhalation. This report contains market size and forecasts of Salbutamol Inhalation in global, including the following market information:
Global Salbutamol Inhalation Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Salbutamol Inhalation Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Salbutamol Inhalation companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Salbutamol Inhalation manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Salbutamol Inhalation Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Salbutamol Inhalation Market Segment Percentages, by Type, 2022 (%)
Ipratropium Bromide
Salbutamol Sulfate
Global Salbutamol Inhalation Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Salbutamol Inhalation Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Others
Global Salbutamol Inhalation Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Salbutamol Inhalation Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Salbutamol Inhalation revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Salbutamol Inhalation revenues share in global market, 2022 (%)
Key companies Salbutamol Inhalation sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Salbutamol Inhalation sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sandoz
Abbott Laboratories
Mylan
Teva Pharmaceutical
Spiriva
GlaxoSmithKline
Cipla
Pharmascience
AstraZeneca
Boehringer Ingelheim
Outline of Major Chapters:
Chapter 1: Introduces the definition of Salbutamol Inhalation, market overview.
Chapter 2: Global Salbutamol Inhalation market size in revenue and volume.
Chapter 3: Detailed analysis of Salbutamol Inhalation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Salbutamol Inhalation in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Salbutamol Inhalation capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Salbutamol Inhalation Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Salbutamol Inhalation Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Salbutamol Inhalation Overall Market Size
2.1 Global Salbutamol Inhalation Market Size: 2022 VS 2029
2.2 Global Salbutamol Inhalation Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Salbutamol Inhalation Sales: 2018-2029
3 Company Landscape
3.1 Top Salbutamol Inhalation Players in Global Market
3.2 Top Global Salbutamol Inhalation Companies Ranked by Revenue
3.3 Global Salbutamol Inhalation Revenue by Companies
3.4 Global Salbutamol Inhalation Sales by Companies
3.5 Global Salbutamol Inhalation Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Salbutamol Inhalation Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Salbutamol Inhalation Product Type
3.8 Tier 1, Tier 2 and Tier 3 Salbutamol Inhalation Players in Global Market
3.8.1 List of Global Tier 1 Salbutamol Inhalation Companies
3.8.2 List of Global Tier 2 and Tier 3 Salbutamol Inhalation Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Salbutamol Inhalation Market Size Markets, 2022 & 2029
4.1.2 Ipratropium Bromide
4.1.3 Salbutamol Sulfate
4.2 By Type - Global Salbutamol Inhalation Revenue & Forecasts
4.2.1 By Type - Global Salbutamol Inhalation Revenue, 2018-2023
4.2.2 By Type - Global Salbutamol Inhalation Revenue, 2024-2029
4.2.3 By Type - Global Salbutamol Inhalation Revenue Market Share, 2018-2029
4.3 By Type - Global Salbutamol Inhalation Sales & Forecasts
4.3.1 By Type - Global Salbutamol Inhalation Sales, 2018-2023
4.3.2 By Type - Global Salbutamol Inhalation Sales, 2024-2029
4.3.3 By Type - Global Salbutamol Inhalation Sales Market Share, 2018-2029
4.4 By Type - Global Salbutamol Inhalation Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Salbutamol Inhalation Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Salbutamol Inhalation Revenue & Forecasts
5.2.1 By Application - Global Salbutamol Inhalation Revenue, 2018-2023
5.2.2 By Application - Global Salbutamol Inhalation Revenue, 2024-2029
5.2.3 By Application - Global Salbutamol Inhalation Revenue Market Share, 2018-2029
5.3 By Application - Global Salbutamol Inhalation Sales & Forecasts
5.3.1 By Application - Global Salbutamol Inhalation Sales, 2018-2023
5.3.2 By Application - Global Salbutamol Inhalation Sales, 2024-2029
5.3.3 By Application - Global Salbutamol Inhalation Sales Market Share, 2018-2029
5.4 By Application - Global Salbutamol Inhalation Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Salbutamol Inhalation Market Size, 2022 & 2029
6.2 By Region - Global Salbutamol Inhalation Revenue & Forecasts
6.2.1 By Region - Global Salbutamol Inhalation Revenue, 2018-2023
6.2.2 By Region - Global Salbutamol Inhalation Revenue, 2024-2029
6.2.3 By Region - Global Salbutamol Inhalation Revenue Market Share, 2018-2029
6.3 By Region - Global Salbutamol Inhalation Sales & Forecasts
6.3.1 By Region - Global Salbutamol Inhalation Sales, 2018-2023
6.3.2 By Region - Global Salbutamol Inhalation Sales, 2024-2029
6.3.3 By Region - Global Salbutamol Inhalation Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Salbutamol Inhalation Revenue, 2018-2029
6.4.2 By Country - North America Salbutamol Inhalation Sales, 2018-2029
6.4.3 US Salbutamol Inhalation Market Size, 2018-2029
6.4.4 Canada Salbutamol Inhalation Market Size, 2018-2029
6.4.5 Mexico Salbutamol Inhalation Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Salbutamol Inhalation Revenue, 2018-2029
6.5.2 By Country - Europe Salbutamol Inhalation Sales, 2018-2029
6.5.3 Germany Salbutamol Inhalation Market Size, 2018-2029
6.5.4 France Salbutamol Inhalation Market Size, 2018-2029
6.5.5 U.K. Salbutamol Inhalation Market Size, 2018-2029
6.5.6 Italy Salbutamol Inhalation Market Size, 2018-2029
6.5.7 Russia Salbutamol Inhalation Market Size, 2018-2029
6.5.8 Nordic Countries Salbutamol Inhalation Market Size, 2018-2029
6.5.9 Benelux Salbutamol Inhalation Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Salbutamol Inhalation Revenue, 2018-2029
6.6.2 By Region - Asia Salbutamol Inhalation Sales, 2018-2029
6.6.3 China Salbutamol Inhalation Market Size, 2018-2029
6.6.4 Japan Salbutamol Inhalation Market Size, 2018-2029
6.6.5 South Korea Salbutamol Inhalation Market Size, 2018-2029
6.6.6 Southeast Asia Salbutamol Inhalation Market Size, 2018-2029
6.6.7 India Salbutamol Inhalation Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Salbutamol Inhalation Revenue, 2018-2029
6.7.2 By Country - South America Salbutamol Inhalation Sales, 2018-2029
6.7.3 Brazil Salbutamol Inhalation Market Size, 2018-2029
6.7.4 Argentina Salbutamol Inhalation Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Salbutamol Inhalation Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Salbutamol Inhalation Sales, 2018-2029
6.8.3 Turkey Salbutamol Inhalation Market Size, 2018-2029
6.8.4 Israel Salbutamol Inhalation Market Size, 2018-2029
6.8.5 Saudi Arabia Salbutamol Inhalation Market Size, 2018-2029
6.8.6 UAE Salbutamol Inhalation Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Sandoz
7.1.1 Sandoz Company Summary
7.1.2 Sandoz Business Overview
7.1.3 Sandoz Salbutamol Inhalation Major Product Offerings
7.1.4 Sandoz Salbutamol Inhalation Sales and Revenue in Global (2018-2023)
7.1.5 Sandoz Key News & Latest Developments
7.2 Abbott Laboratories
7.2.1 Abbott Laboratories Company Summary
7.2.2 Abbott Laboratories Business Overview
7.2.3 Abbott Laboratories Salbutamol Inhalation Major Product Offerings
7.2.4 Abbott Laboratories Salbutamol Inhalation Sales and Revenue in Global (2018-2023)
7.2.5 Abbott Laboratories Key News & Latest Developments
7.3 Mylan
7.3.1 Mylan Company Summary
7.3.2 Mylan Business Overview
7.3.3 Mylan Salbutamol Inhalation Major Product Offerings
7.3.4 Mylan Salbutamol Inhalation Sales and Revenue in Global (2018-2023)
7.3.5 Mylan Key News & Latest Developments
7.4 Teva Pharmaceutical
7.4.1 Teva Pharmaceutical Company Summary
7.4.2 Teva Pharmaceutical Business Overview
7.4.3 Teva Pharmaceutical Salbutamol Inhalation Major Product Offerings
7.4.4 Teva Pharmaceutical Salbutamol Inhalation Sales and Revenue in Global (2018-2023)
7.4.5 Teva Pharmaceutical Key News & Latest Developments
7.5 Spiriva
7.5.1 Spiriva Company Summary
7.5.2 Spiriva Business Overview
7.5.3 Spiriva Salbutamol Inhalation Major Product Offerings
7.5.4 Spiriva Salbutamol Inhalation Sales and Revenue in Global (2018-2023)
7.5.5 Spiriva Key News & Latest Developments
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Company Summary
7.6.2 GlaxoSmithKline Business Overview
7.6.3 GlaxoSmithKline Salbutamol Inhalation Major Product Offerings
7.6.4 GlaxoSmithKline Salbutamol Inhalation Sales and Revenue in Global (2018-2023)
7.6.5 GlaxoSmithKline Key News & Latest Developments
7.7 Cipla
7.7.1 Cipla Company Summary
7.7.2 Cipla Business Overview
7.7.3 Cipla Salbutamol Inhalation Major Product Offerings
7.7.4 Cipla Salbutamol Inhalation Sales and Revenue in Global (2018-2023)
7.7.5 Cipla Key News & Latest Developments
7.8 Pharmascience
7.8.1 Pharmascience Company Summary
7.8.2 Pharmascience Business Overview
7.8.3 Pharmascience Salbutamol Inhalation Major Product Offerings
7.8.4 Pharmascience Salbutamol Inhalation Sales and Revenue in Global (2018-2023)
7.8.5 Pharmascience Key News & Latest Developments
7.9 AstraZeneca
7.9.1 AstraZeneca Company Summary
7.9.2 AstraZeneca Business Overview
7.9.3 AstraZeneca Salbutamol Inhalation Major Product Offerings
7.9.4 AstraZeneca Salbutamol Inhalation Sales and Revenue in Global (2018-2023)
7.9.5 AstraZeneca Key News & Latest Developments
7.10 Boehringer Ingelheim
7.10.1 Boehringer Ingelheim Company Summary
7.10.2 Boehringer Ingelheim Business Overview
7.10.3 Boehringer Ingelheim Salbutamol Inhalation Major Product Offerings
7.10.4 Boehringer Ingelheim Salbutamol Inhalation Sales and Revenue in Global (2018-2023)
7.10.5 Boehringer Ingelheim Key News & Latest Developments
8 Global Salbutamol Inhalation Production Capacity, Analysis
8.1 Global Salbutamol Inhalation Production Capacity, 2018-2029
8.2 Salbutamol Inhalation Production Capacity of Key Manufacturers in Global Market
8.3 Global Salbutamol Inhalation Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Salbutamol Inhalation Supply Chain Analysis
10.1 Salbutamol Inhalation Industry Value Chain
10.2 Salbutamol Inhalation Upstream Market
10.3 Salbutamol Inhalation Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Salbutamol Inhalation Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
112
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
116
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
115
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
112
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
115
|
View Report